Related Experiment Video
Updated: Aug 3, 2026
Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue
Published on: August 15, 2012
Vitamin E suppression of microglial activation is neuroprotective
Y Li1, L Liu, S W Barger
1Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Abstract:
Neurotoxic microglial-neuronal interactions have been implicated in the pathogenesis of various neurodegenerative diseases such as Alzheimer's disease, and vitamin E has been shown to have direct neuroprotective effects. To determine whether vitamin E also has indirect neuroprotective effects through suppression of microglial activation, we used a microglial-neuronal coculture. Lipopolysaccharide (LPS) treatment of a microglial cell line (N9) induced a time-dependent activation of both p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor-kappaB (NFkappaB), with consequent increases in interleukin-1alpha (IL-1alpha), tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO) production. Differentiated neuronal cells (PC12 cells treated with nerve growth factor) exhibited marked loss of processes and decreased survival when cocultured with LPS-activated microglia. Preincubation of microglia with vitamin E diminished this neurotoxic effect, independently of direct effects of the antioxidant on the neuronal cells. Microglial NO production and the induction of IL-1alpha and TNFalpha expression also were attenuated by vitamin E. Such antiinflammatory effects of vitamin E were correlated with suppression of p38 MAPK and NFkappaB activation and were mimicked by an inhibition of either p38 MAPK (by SB203580) or NFkappaB (by decoy oligonucleotides). These results suggest that, in addition to the beneficial effects of providing direct antioxidant protection to neurons reported by others, vitamin E may provide neuroprotection in vivo through suppression of signaling events necessary for microglial activation.
Insights
Vitamin E protects neurons by reducing harmful microglial activation, a key factor in neurodegenerative diseases like Alzheimer's. It suppresses inflammatory pathways, offering indirect neuroprotection beyond its antioxidant properties.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglial activation contributes to neurodegeneration in diseases like Alzheimer's.
- Vitamin E is known for direct neuroprotective antioxidant effects.
- The indirect neuroprotective role of vitamin E via microglial modulation is unexplored.
Purpose of the Study:
- To investigate if vitamin E indirectly protects neurons by suppressing microglial activation.
- To elucidate the molecular mechanisms underlying vitamin E's effects on microglia-neuron interactions.
Main Methods:
- Utilized a microglial-neuronal co-culture model.
- Stimulated microglial activation using lipopolysaccharide (LPS).
- Assessed neurotoxicity, microglial inflammatory markers (IL-1α, TNF-α, NO), and signaling pathways (p38 MAPK, NFκB).
Main Results:
- LPS-activated microglia induced significant neuronal damage and reduced survival.
- Vitamin E pre-treatment of microglia attenuated neuronal toxicity and suppressed microglial production of IL-1α, TNF-α, and NO.
- Vitamin E inhibited LPS-induced activation of p38 MAPK and NFκB signaling pathways in microglia.
- These anti-inflammatory effects of vitamin E were mimicked by specific inhibitors of p38 MAPK and NFκB.
Conclusions:
- Vitamin E confers neuroprotection not only through direct antioxidant effects but also by suppressing microglial activation.
- Vitamin E inhibits key signaling pathways (p38 MAPK, NFκB) essential for microglial inflammatory responses.
- These findings suggest vitamin E as a potential therapeutic agent for neurodegenerative diseases by modulating neuroinflammation.
